*By Conor White*
Reports indicate that widespread 5G may arrive in 2019, and providers are scurrying to meet that unofficial deadline in the wake of Verizon's recent announcement that it will partner with Samsung to release a 5G phone by June.
But until then, 5G is a nebulous goal. "In a sense, 5G in a very real sense doesn't exist right now,"Pete Pachal, Mashable's tech editor told Cheddar Tuesday.
"Right now, there are lot of people, a lot of companies, tripping over themselves to be first at 5G and have those bragging rights," Pachal said.
One company that may sit this round out, at least initially, is Apple ($APPL). The company is executing a time-consuming switch from Qualcomm to Intel processors.
"It's going to take a little while to get that integrated with Apple's chips and its technology," Pachal said. "So 2020 looks like the 5G iPhone."
Even if consumers have to wait for Apple and the iPhone to get on board, 5G should usher in a new age of connectivity.
"If it's even half the promises they're making, it's going to be a tremendous shift in wireless," Pachal said.
For full interview [click here](https://cheddar.com/videos/the-future-of-5g-technology).
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
